Variant report

Variant	nsv6457
Chromosome Location	chr9:2228493-2271756
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:871)
CpG islands
(count:366)
Chromatin interactive
region (count:25)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:871 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:2241752-2242185	HepG2	liver:	n/a	n/a
2	ARID3A	chr9:2241873-2242174	K562	blood:	n/a	n/a
3	ATF2	chr9:2241526-2242216	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF2	chr9:2241499-2242598	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr9:2241813-2242242	GM12878	blood:	n/a	n/a
6	ATF2	chr9:2229314-2229763	GM12878	blood:	n/a	n/a
7	ATF2	chr9:2229291-2229713	GM12878	blood:	n/a	n/a
8	ATF2	chr9:2241795-2242260	GM12878	blood:	n/a	n/a
9	ATF3	chr9:2241780-2242300	A549	lung:	n/a	n/a
10	BACH1	chr9:2241631-2242354	H1-hESC	embryonic stem cell:	n/a	n/a
11	BATF	chr9:2271359-2271697	GM12878	blood:	n/a	n/a
12	BATF	chr9:2230017-2230285	GM12878	blood:	n/a	chr9:2230183-2230193 chr9:2230182-2230193
13	BATF	chr9:2271341-2271745	GM12878	blood:	n/a	n/a
14	BCL11A	chr9:2241903-2242115	GM12878	blood:	n/a	n/a
15	BCL3	chr9:2241690-2242337	A549	lung:	n/a	n/a
16	BCL3	chr9:2241755-2242399	A549	lung:	n/a	n/a
17	BCLAF1	chr9:2241766-2242280	GM12878	blood:	n/a	n/a
18	BCLAF1	chr9:2229240-2229763	GM12878	blood:	n/a	chr9:2229561-2229570
19	BCLAF1	chr9:2241790-2242233	GM12878	blood:	n/a	n/a
20	BHLHE40	chr9:2241822-2242611	HepG2	liver:	n/a	n/a
21	BHLHE40	chr9:2241630-2242313	K562	blood:	n/a	n/a
22	BHLHE40	chr9:2241927-2242471	GM12878	blood:	n/a	n/a
23	BRCA1	chr9:2241818-2242305	H1-hESC	embryonic stem cell:	n/a	n/a
24	BRCA1	chr9:2242326-2242348	GM12878	blood:	n/a	n/a
25	CBX3	chr9:2241820-2242161	K562	blood:	n/a	n/a
26	CBX3	chr9:2241725-2242505	HCT-116	colon:	n/a	n/a
27	CBX3	chr9:2260461-2261583	HCT-116	colon:	n/a	n/a
28	CBX3	chr9:2260466-2261875	HCT-116	colon:	n/a	n/a
29	CBX3	chr9:2241713-2242381	HCT-116	colon:	n/a	n/a
30	CCNT2	chr9:2241616-2242096	K562	blood:	n/a	n/a
31	CEBPB	chr9:2241880-2242260	A549	lung:	n/a	n/a
32	CEBPB	chr9:2228159-2228502	A549	lung:	n/a	n/a
33	CEBPB	chr9:2228094-2228527	H1-hESC	embryonic stem cell:	n/a	n/a
34	CEBPB	chr9:2244398-2244576	H1-hESC	embryonic stem cell:	n/a	chr9:2244415-2244426
35	CEBPB	chr9:2228196-2228506	IMR90	lung:	n/a	n/a
36	CEBPB	chr9:2270668-2270923	HepG2	liver:	n/a	chr9:2270774-2270785 chr9:2270773-2270784 chr9:2270773-2270784
37	CEBPB	chr9:2228058-2228629	HCT-116	colon:	n/a	n/a
38	CEBPB	chr9:2241958-2242358	IMR90	lung:	n/a	n/a
39	CEBPB	chr9:2244293-2244527	A549	lung:	n/a	chr9:2244415-2244426
40	CEBPB	chr9:2241419-2242557	H1-hESC	embryonic stem cell:	n/a	n/a
41	CEBPB	chr9:2228058-2228601	A549	lung:	n/a	n/a
42	CEBPB	chr9:2260562-2261566	HCT-116	colon:	n/a	n/a
43	CEBPB	chr9:2244301-2244558	HepG2	liver:	n/a	chr9:2244415-2244426
44	CEBPB	chr9:2270671-2270953	A549	lung:	n/a	chr9:2270774-2270785 chr9:2270773-2270784 chr9:2270773-2270784
45	CEBPB	chr9:2241906-2242117	GM12878	blood:	n/a	n/a
46	CEBPB	chr9:2270673-2270933	IMR90	lung:	n/a	chr9:2270774-2270785 chr9:2270773-2270784 chr9:2270773-2270784
47	CEBPD	chr9:2241904-2242154	HepG2	liver:	n/a	n/a
48	CHD1	chr9:2241921-2242230	H1-hESC	embryonic stem cell:	n/a	n/a
49	CHD1	chr9:2241257-2241480	H1-hESC	embryonic stem cell:	n/a	n/a
50	CHD2	chr9:2241878-2242214	GM12878	blood:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:2234921-2234971	SKMC	muscle:	n/a
2	chr9:2242468-2242518	Hela-S3	cervix:	n/a
3	chr9:2241688-2241738	BJ	skin:	n/a
4	chr9:2242468-2242518	GM12892	blood:	n/a
5	chr9:2234921-2234971	AG04450	lung:	fetal
6	chr9:2241892-2241942	HEK293	kidney:	embryo
7	chr9:2241256-2241306	HRCEpiC	kidney:	n/a
8	chr9:2241256-2241306	HCPEpiC	choroid plexus:	n/a
9	chr9:2241256-2241306	NHDF-neo	bronchial:	n/a
10	chr9:2234921-2234971	GM12891	blood:	n/a
11	chr9:2241688-2241738	HPAEpiC	pulmonary alveolar:	n/a
12	chr9:2241256-2241306	IMR90	lung:	fetal
13	chr9:2242468-2242518	BE2_C	brain:	n/a
14	chr9:2241256-2241306	ECC-1	luminal epithelium:	n/a
15	chr9:2241892-2241942	CMK	blood:	n/a
16	chr9:2241892-2241942	T-47D	breast:	n/a
17	chr9:2239671-2239721	BJ	skin:	n/a
18	chr9:2241256-2241306	AG09319	gingival:	n/a
19	chr9:2242468-2242518	CMK	blood:	n/a
20	chr9:2239671-2239721	ovcar-3	ovarian:	n/a
21	chr9:2241688-2241738	NHDF-neo	bronchial:	n/a
22	chr9:2234921-2234971	GM19239	blood:	n/a
23	chr9:2241892-2241942	HCT-116	colon:	n/a
24	chr9:2239671-2239721	HUVEC	blood vessel:	n/a
25	chr9:2242468-2242518	PFSK-1	brain:	n/a
26	chr9:2234921-2234971	NT2-D1	testis:	n/a
27	chr9:2239671-2239721	SAEC	small airway:	n/a
28	chr9:2239671-2239721	HMEC	breast:	n/a
29	chr9:2241256-2241306	LNCaP	prostate:	n/a
30	chr9:2239671-2239721	Caco-2	colon:	n/a
31	chr9:2239671-2239721	ProgFib	skin:	n/a
32	chr9:2239671-2239721	MCF-7	breast:	n/a
33	chr9:2241256-2241306	HMEC	breast:	n/a
34	chr9:2241256-2241306	HRPEpiC	eye:	n/a
35	chr9:2234921-2234971	MCF-7	breast:	n/a
36	chr9:2239671-2239721	GM19239	blood:	n/a
37	chr9:2242468-2242518	ECC-1	luminal epithelium:	n/a
38	chr9:2239671-2239721	HCM	heart:	n/a
39	chr9:2234921-2234971	NH-A	brain:	n/a
40	chr9:2239671-2239721	RPTEC	kidney:	n/a
41	chr9:2239671-2239721	HCPEpiC	choroid plexus:	n/a
42	chr9:2239671-2239721	SK-N-SH	brain:	n/a
43	chr9:2241892-2241942	MCF-7	breast:	n/a
44	chr9:2234921-2234971	LNCaP	prostate:	n/a
45	chr9:2234921-2234971	RPTEC	kidney:	n/a
46	chr9:2241892-2241942	HUVEC	blood vessel:	n/a
47	chr9:2242468-2242518	RPTEC	kidney:	n/a
48	chr9:2242468-2242518	IMR90	lung:	fetal
49	chr9:2241688-2241738	CMK	blood:	n/a
50	chr9:2241892-2241942	Hepatocyte	liver:	n/a

(count:25 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:2226247..2228750-chr9:2234155..2236078,2	MCF-7	breast:
2	chr9:2240721..2243292-chr9:2621569..2623384,2	MCF-7	breast:
3	chr9:2243537..2246838-chr9:2247520..2250621,4	MCF-7	breast:
4	chr9:2257367..2260216-chr9:2810940..2813820,2	MCF-7	breast:
5	chr9:2244966..2246945-chr9:2263682..2266605,2	MCF-7	breast:
6	chr9:2226247..2228750-chr9:2234155..2236078,2	MCF-7	breast:
7	chr9:2266333..2269283-chr9:2269848..2272589,2	K562	blood:
8	chr9:2256748..2259220-chr9:2292192..2293911,2	MCF-7	breast:
9	chr9:2228114..2228719-chr9:2625246..2626097,2	MCF-7	breast:
10	chr9:2229879..2232148-chr9:2238435..2240178,2	K562	blood:
11	chr9:2231807..2233920-chr9:2241447..2243691,2	MCF-7	breast:
12	chr9:2243537..2246838-chr9:2247520..2250621,4	MCF-7	breast:
13	chr9:2244966..2246945-chr9:2263682..2266605,2	MCF-7	breast:
14	chr9:2266333..2269283-chr9:2269848..2272589,2	K562	blood:
15	chr9:2016060..2018467-chr9:2241276..2243249,2	K562	blood:
16	chr9:2242145..2244162-chr9:2246197..2248614,2	MCF-7	breast:
17	chr9:2242145..2244162-chr9:2246197..2248614,2	MCF-7	breast:
18	chr9:2217416..2220117-chr9:2231617..2233140,2	MCF-7	breast:
19	chr9:2232135..2233681-chr9:2242107..2243678,2	MCF-7	breast:
20	chr9:2229721..2232093-chr9:2241469..2243158,2	MCF-7	breast:
21	chr9:2229721..2232093-chr9:2241469..2243158,2	MCF-7	breast:
22	chr9:2231807..2233920-chr9:2241447..2243691,2	MCF-7	breast:
23	chr9:2255030..2255773-chr9:2600478..2601011,2	MCF-7	breast:
24	chr9:2229879..2232148-chr9:2238435..2240178,2	K562	blood:
25	chr9:2232135..2233681-chr9:2242107..2243678,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SMARCA2-5	chr9:2264485-2264628	NONHSAT129991
2	lnc-KIAA0020-6	chr9:2228963-2229241	NONHSAT129990

No data

Variant related genes	Relation type
RN7SL592P	TF binding region
RN7SL592P	CpG island
ENSG00000147852	chromatin interactions
ENSG00000080503	chromatin interactions
ENSG00000236404	chromatin interactions

Extended variants
information (count: 2479 )
Associated
traits (count: 100 )

Variant overlapped rSNPs/rCNVs (count:2479 , 50 per page) page: 1 2 3 4 5 6 7 ... 50

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs181229152	chr9:2228503-2228504	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs113136880	chr9:2228505-2228506	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs377549372	chr9:2228519-2228520	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs185875187	chr9:2228605-2228606	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs532787049	chr9:2228606-2228607	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs144181761	chr9:2228617-2228618	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs146057741	chr9:2228630-2228631	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs528562905	chr9:2228641-2228642	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs529165828	chr9:2228657-2228658	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs7045699	chr9:2228689-2228690	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs116411192	chr9:2228696-2228697	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs151019843	chr9:2228714-2228715	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs569851774	chr9:2228728-2228729	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs10491704	chr9:2228755-2228756	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs75503823	chr9:2228765-2228766	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs191383308	chr9:2228768-2228769	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs182003846	chr9:2228774-2228775	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs554151436	chr9:2228801-2228802	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs574135370	chr9:2228819-2228820	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs543009739	chr9:2228863-2228864	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs564036817	chr9:2228865-2228866	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs115162733	chr9:2228892-2228893	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs546387556	chr9:2228896-2228897	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs558290155	chr9:2228900-2228901	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs559643437	chr9:2228914-2228915	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs568728167	chr9:2228923-2228924	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs528617190	chr9:2228926-2228927	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs139388560	chr9:2228943-2228944	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs147895088	chr9:2228944-2228945	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs35640858	chr9:2228945-2228946	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs139102549	chr9:2228947-2228948	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs149477086	chr9:2228952-2228953	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs397734083	chr9:2228957-2228958	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs76774164	chr9:2228958-2228959	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs113799625	chr9:2228970-2228971	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
36	rs562146403	chr9:2228975-2228976	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
37	rs530954385	chr9:2228976-2228977	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
38	rs7046122	chr9:2228983-2228984	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
39	rs569946160	chr9:2229012-2229013	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
40	rs370892221	chr9:2229020-2229021	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
41	rs538513530	chr9:2229030-2229031	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
42	rs552372977	chr9:2229068-2229069	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
43	rs565506149	chr9:2229069-2229070	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
44	rs534496082	chr9:2229116-2229117	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
45	rs554273847	chr9:2229135-2229136	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
46	rs10757293	chr9:2229141-2229142	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs559663163	chr9:2229171-2229172	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
48	rs537090519	chr9:2229176-2229177	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
49	rs147785926	chr9:2229194-2229195	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
50	rs577468326	chr9:2229231-2229232	Enhancers Weak transcription Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:100)

Disease	PMID	Source
Gastric cancer	16715143	CNVD
Glioblastoma multiforme	22286061	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Disorders of sex development	21048976	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Esophageal cancer	21851588	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Myelofibrosis	22110671	CNVD
Developmental delay	21373258	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hepatocellular carcinoma	18803288	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:993 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:2223600-2240800	Weak transcription	HUES64 Cell Line	embryonic stem cell
2	chr9:2224600-2229400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr9:2226800-2229000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
4	chr9:2227200-2229200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
5	chr9:2227400-2234400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
6	chr9:2227600-2229400	Enhancers	Pancreas	Pancrea
7	chr9:2227800-2229400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr9:2227800-2230200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
9	chr9:2227800-2231400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
10	chr9:2227800-2231600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
11	chr9:2227800-2231600	Weak transcription	Ovary	ovary
12	chr9:2227800-2234400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
13	chr9:2228000-2229000	Enhancers	Primary neutrophils fromperipheralblood	blood
14	chr9:2228000-2229800	Enhancers	Primary hematopoietic stem cells short term culture	blood
15	chr9:2228000-2231000	Enhancers	Primary monocytes fromperipheralblood	blood
16	chr9:2228000-2231200	Weak transcription	Osteobl	bone
17	chr9:2228000-2231400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr9:2228000-2234600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
19	chr9:2228200-2229200	Enhancers	Primary B cells from cord blood	blood
20	chr9:2228200-2229200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr9:2228200-2229400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
22	chr9:2228200-2229600	Enhancers	Right Atrium	heart
23	chr9:2228200-2229800	Enhancers	HMEC	breast
24	chr9:2228200-2230400	Enhancers	Primary B cells from peripheral blood	blood
25	chr9:2228400-2229200	Enhancers	Fetal Thymus	thymus
26	chr9:2228400-2229200	Enhancers	Spleen	Spleen
27	chr9:2228400-2229200	Enhancers	GM12878-XiMat	blood
28	chr9:2228400-2229400	Enhancers	ES-I3 Cell Line	embryonic stem cell
29	chr9:2228400-2229400	Enhancers	Placenta	Placenta
30	chr9:2228400-2229800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
31	chr9:2228400-2229800	Enhancers	HepG2	liver
32	chr9:2228400-2230000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
33	chr9:2228400-2230000	Enhancers	Primary hematopoietic stem cells	blood
34	chr9:2228400-2230000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
35	chr9:2228400-2230000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
36	chr9:2228400-2230200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
37	chr9:2228400-2230200	Enhancers	Stomach Mucosa	stomach
38	chr9:2228600-2228800	Enhancers	NHEK	skin
39	chr9:2228800-2229400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr9:2228800-2230400	Enhancers	Placenta Amnion	Placenta Amnion
41	chr9:2228800-2234200	Weak transcription	NHEK	skin
42	chr9:2229000-2229200	Enhancers	Duodenum Mucosa	Duodenum
43	chr9:2229000-2229200	Enhancers	Fetal Muscle Leg	muscle
44	chr9:2229000-2229200	Enhancers	Left Ventricle	heart
45	chr9:2229000-2229400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
46	chr9:2229000-2230800	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr9:2229200-2229400	Enhancers	Right Ventricle	heart
48	chr9:2229200-2229600	Flanking Active TSS	Primary B cells from cord blood	blood
49	chr9:2229200-2229600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
50	chr9:2229200-2229800	Enhancers	Breast Myoepithelial Primary Cells	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links